$XRAY (DENTSPLY International Inc.)

$XRAY {{ '2015-10-28T17:04:05+0000' | timeago}} • Webcast

$XRAY's net acquisition growth rate was 0.3% negative in 3Q15 primarily reflecting the impact of small divestitures of non-core products that more than offset the impact from acquisitions. The impact of discontinued products reduced the internal growth rate by about 50 basis points in 3Q15.

$XRAY {{ '2017-07-14T15:40:42+0000' | timeago}} • Announcement

Dental solutions provider $XRAY declared a quarterly cash dividend of $0.0875 per common share. The corresponding annual rate has increased 12.9% to $0.35 per share from the prior annual rate of $0.31 per share. The dividend is payable on April 13, 2017 to shareholders of record on March 31, 2017.

$XRAY {{ '2017-06-28T12:56:52+0000' | timeago}} • Announcement

$XRAY agreed to a new distribution agreement in Canada. The company announced a new distribution agreement with Henry Schein Canada. This new agreement, effective Sept. 1, 2017 through Dec. 31, 2020, will expand the market opportunity for $XRAY's leading brands and integrated solutions, including Cerec and Schick.

$HSIC {{ '2017-06-28T12:03:39+0000' | timeago}} • Announcement

$HSIC extended its existing agreement in Canada with $XRAY to include the CEREC CAD/CAM restoration system and the Schick line of imaging sensors. Henry Schein Canada will represent the entire $XRAY product line, effective Sept. 1, 2017. The revised agreement is expected to be neutral to $HSIC EPS in 2017 and accretive thereafter.

$XRAY {{ '2017-06-16T15:19:56+0000' | timeago}} • Announcement

Dental solutions provider $XRAY has extended its partnership with Pacific Dental Services (PDS) by five more years. Under the agreement, PDS and the 1,600-plus dentists it supports will get access to Dentply’s consumables and the new technologies and services it offers. PDS-supported practices will be offered with Dentsply equipment and technology.

$XRAY {{ '2017-05-09T18:40:46+0000' | timeago}} • Webcast

$XRAY stated that it sees rest of the world as its fastest growing region. Though sales have been comparatively slow during 1Q17 in Asia, $XRAY expects it to pick up pace by 2Q17.

$XRAY {{ '2017-05-09T11:11:53+0000' | timeago}} • Announcement

$XRAY announced a new distribution agreement with $PDCO, continuing its partnership over many years. Additionally, $XRAY announced a new three-year agreement with $HSIC, effective September 1, 2017 to distribute $XRAY's full line of dental equipment in the US.

$XRAY {{ '2017-05-09T11:06:45+0000' | timeago}} • Announcement

In 1Q17, $XRAY's net sales for Dental and Healthcare Consumables rose 4.6% YoY to $511.2MM, while that from Technologies improved 37.2% YoY to $389.3MM.

$XRAY {{ '2017-05-09T11:02:40+0000' | timeago}} • Announcement

$XRAY reiterated its EPS guidance for FY17 in the range of $2.80 to $2.90 per diluted share.

$XRAY {{ '2017-05-09T11:01:21+0000' | timeago}} • Announcement

$XRAY, a maker of dental products, reported net earnings that halved in 1Q17 to $59.8MM, or $0.26 per share, compared to $125MM, or $0.70 per share a year ago. This was despite a 16.6% increase in net revenue to $900.5MM. Excluding special items, $XRAY earned $0.49 per share.

$XRAY {{ '2017-02-17T14:09:56+0000' | timeago}} • Announcement

$XRAY BoD declared a quarterly cash dividend of $0.0875 per common share, payable on April 13, 2017, to shareholders of record on March 31, 2017.

$XRAY {{ '2017-02-17T12:23:32+0000' | timeago}} • Announcement

$XRAY expects its FY17 non-GAAP earnings to be in the range of $2.80-2.90 per diluted share.

$XRAY {{ '2017-02-17T12:18:50+0000' | timeago}} • Announcement

$XRAY On geographic basis, U.S. reported net sales of $329MM, rose 48.2% YoY from $222MM during 4Q15. Excluding precious metals, U.S. reported net sales of $327.7MM, up 48.5%. Net sales in Europe rose 37.7% YoY to $402.4MM.

$XRAY {{ '2017-02-17T12:11:25+0000' | timeago}} • Announcement

Dental products manufacturer $XRAY reported 82.5% rise in its 4Q16 earnings, helped by increase in net sales. The company's net income rose to $107MM, or $0.46 per share, compared to $58.6MM, or $0.41 per share during 4Q15. Net sales during the quarter rose 48.5% YoY to $996.5MM from $671.1MM. Excluding items, $XRAY earned $0.67 per share.

$XRAY {{ '2016-11-04T18:22:54+0000' | timeago}} • Webcast

$XRAY reported that it will not buyback shares at irregular pace at this point. The company said that if there is a good opportunity, it will buyback shares. $XRAY added that its first priority with regards to capital deployment is acquisitions and it plans to do small acquisitions in the next year.

$XRAY {{ '2016-11-04T17:35:45+0000' | timeago}} • Webcast

So far $XRAY has been expecting constant currency sales growth of 4-6% and internal sales growth of 3-5% for FY16. At current exchange rate, this would translate to reported revenues, excluding precious metal, of approx. $3.73-3.81Bil. The company now expects revenues to be at the low end of the previously expressed range.

$XRAY {{ '2016-11-04T17:18:17+0000' | timeago}} • Webcast

In its second full quarter after the Dentsply and Sirona merger, the combined company $XRAY reported that 3Q16 revenues came in a bit lower than company's expectation. In U.S., Consumables segment sales declined due to soft summer and a change in dealer buying patterns. $XRAY believes that growth will pick up in the U.S. market in 4Q16.

$XRAY {{ '2016-11-04T12:52:24+0000' | timeago}} • Announcement

$XRAY lifted the bottom end of its 2016 adjusted EPS outlook. Adjusted EPS is now anticipated to be $2.75-2.80 compared to the previous range of $2.70 to $2.80. During 3Q16, $XRAY completed the acquisition of MIS Implants, an Israel-based dental implant systems manufacturer.

$XRAY {{ '2016-11-04T12:42:55+0000' | timeago}} • Announcement

$XRAY reported a rise in 3Q16 profit, helped by the sales growth in the Rest of World. Net income attributable to the company was $92.5MM or $0.39 per diluted share compared to $84.5MM or $0.59 per diluted share in 3Q15. Net sales increased 47% to $954.2MM. Non-GAAP EPS was $0.66.

$XRAY {{ '2016-08-05T13:54:50+0000' | timeago}} • Webcast

Jon Block of Stifel asks about the timing and close and the level of accretion from the MIS deal in the first 12 months. CFO Ulrich Michel said that $XRAY fully expects MIS to grow in the high single digits. He added that the acquisition will close this year and in the first 12 months, it will be accretive to adjusted EPS.

$XRAY {{ '2016-08-05T13:47:25+0000' | timeago}} • Webcast

Robert Willoughby of Credit Suisse wants to know the accounts payable balance at the end of 2Q16. $XRAY CFO Ulrich Michel said that the accounts payable balance was $227.1MM at the end of the quarter.

Recent Transcripts

ISRG (Intuitive Surgical, Inc.)
Thursday, July 20 2017 - 8:30pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
UNH (UnitedHealth Group Incorporated)
Tuesday, July 18 2017 - 12:45pm
USPH (US Physical Therapy Inc.)
Thursday, June 29 2017 - 2:30pm
CMD (Cantel Medical Corp.)
Thursday, June 8 2017 - 3:00pm
TEAR (TearLab Corporation)
Monday, May 15 2017 - 8:30pm
PBH (Prestige Brands Holdings, Inc.)
Thursday, May 11 2017 - 12:30pm
PMC (PharMerica Corporation)
Wednesday, May 10 2017 - 2:00pm
STE (Steris Plc)
Tuesday, May 9 2017 - 2:00pm
XRAY (DENTSPLY International Inc.)
Tuesday, May 9 2017 - 12:30pm
ENDP (Endo International plc)
Tuesday, May 9 2017 - 12:30pm
HAE (Haemonetics Corporation)
Monday, May 8 2017 - 12:00pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 9:00pm
OFIX (Orthofix International N.V.)
Thursday, May 4 2017 - 8:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, May 4 2017 - 12:00pm
GMED (Globus Medical, Inc.)
Wednesday, May 3 2017 - 9:30pm
MASI (Masimo Corporation)
Wednesday, May 3 2017 - 8:30pm
Q (Quintiles Transnational Holdings Inc.)
Wednesday, May 3 2017 - 1:00pm
WCG (WellCare Health Plans, Inc.)
Wednesday, May 3 2017 - 12:00pm
PFE (Pfizer Inc.)
Tuesday, May 2 2017 - 2:00pm

AlphaGraphics you may like